It is estimated that as many as 90 percent of people in industrialized countries who die every day, die from diseases of aging such as heart disease, stroke, and cancer. Of those still alive the numbers aren’t much more reassuring. More than 80 percent of people over the age of 65 have a chronic medical … Continue reading Join us to hear how stem cell and gene therapy are taking on diseases of aging
CIRM News
The long road to developing a therapy for epilepsy
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Good science takes time. That’s an important guiding phrase for researchers looking to develop new therapies. But it’s also a frustrating reality for patients who are waiting for something to help them now. That point was driven home last week when the governing board of the … Continue reading The long road to developing a therapy for epilepsy
The power of the patient advocate: how a quick visit led to an $11M grant to fund a clinical trial
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Members of NFOSD visiting UC Davis in 2013 At the California Institute for Regenerative Medicine (CIRM) we are fortunate in having enough money to fund the most promising research to be tested in a clinical trial. Those are expensive projects, often costing tens of millions of … Continue reading The power of the patient advocate: how a quick visit led to an $11M grant to fund a clinical trial
The California Institute for Regenerative Medicine (CIRM) awards $5.8 million for prostate cancer research to USC
The American Cancer Society estimates that this year in the United States, there will be 268,490 new cases of prostate cancer. It also estimates that 34,500 men will die from the cancer in 2022. Other than skin cancer, prostate cancer is the most common cancer in American men. These stark statistics are why the California … Continue reading The California Institute for Regenerative Medicine (CIRM) awards $5.8 million for prostate cancer research to USC
And we’re back!
You may have noticed last week that the official CIRM website and our beloved Stem Cellar blog were offline for a few days. While we received some fun theories about the outage from our readers (we were not “hacked”, and it was not a ransomware attack), the explanation is much more technical: CIRM’s websites experienced … Continue reading And we’re back!
IBSC directors bring in nearly $12 million to fund the future of bimolecular research at UC Santa Cruz
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Left to right: Lindsay Hinck and Camilla Forsberg UC Santa Cruz professors Camilla Forsberg and Lindsay Hinck are not only pushing boundaries in their field as the female-led program directors of the Institute for the Biology of Stem Cells (IBSC), they’ve also been looking for ways … Continue reading IBSC directors bring in nearly $12 million to fund the future of bimolecular research at UC Santa Cruz
It’s hard to be modest when people keep telling you how good you are
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST I have a confession. Deep down I’m shallow. So when something I am part of is acknowledged as one of the best, I delight in it (my fellow bloggers Katie and Esteban also delight in it, I am just more shameless about letting everyone know.) And … Continue reading It’s hard to be modest when people keep telling you how good you are
New funding opportunity in CIRM’s Discovery stage programs: the Foundation Awards
Applications for CIRM’s new Discovery stage Foundation Awards (DISC 0) are due May 26th, 2022 by 2:00 PM PDT. The California Institute for Regenerative Medicine (CIRM) is pleased to announce a brand new funding opportunity within our Discovery stage programs, the DISC 0 Foundation Awards which will support rigorous studies addressing critical basic knowledge gaps in the … Continue reading New funding opportunity in CIRM’s Discovery stage programs: the Foundation Awards
Stem cell agency invests in therapy using killer cells to target colorectal, breast and ovarian cancers
While there have been some encouraging advances in treating cancer in recent decades, there are still many cancers that either resist treatment or recur after treatment. Today the governing Board of the California Institute for Regenerative Medicine (CIRM) approved investing in a therapy targeting some of these hard-to-treat tumors. BioEclipse Therapeutics Inc. was awarded nearly … Continue reading Stem cell agency invests in therapy using killer cells to target colorectal, breast and ovarian cancers
How two women are fighting back against Lou Gehrig’s disease
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Mary Ann Wittenberg (left) and Nadia Sethi Lou Gehrig's disease, or ALS, is a nasty degenerative condition that destroys the brain cells controlling movement. People with ALS suffer a progressive loss of ability to walk, talk, eat and breathe. The average life expectancy for someone diagnosed … Continue reading How two women are fighting back against Lou Gehrig’s disease
The Stem Cellar 